SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech binary events
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (59)8/6/2003 8:40:52 AM
From: nigel bates  Read Replies (1) of 295
 
A month later, and still waiting for the Neovastat news.

There is some discussion of RCC survival times on Yahoo - finance.messages.yahoo.com (and following several posts).

Any comments on this ?
...I am close to 99.9% sure the placebo MST can’t be over 10 months. As the health parameters of the Neovastat population are fully compatible with a progressive RCC population and therefore a MST below 10 months, it is incredibly difficult to account for the length of the trial without Neovastat being effective...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News